Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinomaOlwen M Hahn, Cheng Yang, Milica Medved, et al.
Environment International|November 15, 2016
Effect of a clean stove intervention on inflammatory biomarkers in pregnant women in Ibadan, Nigeria: A randomized controlled studyChristopher O Olopade, Elizabeth Frank, Emily Bartlett, et al.
Anesthesia and Analgesia|October 17, 2025
A Combined Intravenous and Oral Metoprolol Regimen to Reduce Perioperative Myocardial Injury: The ORION TrialPeter Nagele, Mohammad A Helwani, Eslam Samaha, et al.
The Journal of Urology|December 8, 2025
Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial NephrectomyAlon Lazarovich, Samuel Tremblay, Charlie Nottingham, et al.
Clinical Lung Cancer|November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trialEzra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.
Oncotarget|February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancerShalin Shah, Kevin Wood, Brian Labadie, et al.
Clinical Genitourinary Cancer|September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal CarcinomaRandy F Sweis, Milica Medved, Shannon Towey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignanciesTodd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.
Blood|March 8, 2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesSonali M Smith, Michelle M Le Beau, Dezheng Huo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB AlterationsNoura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinomaOlwen M Hahn, Cheng Yang, Milica Medved, et al.
Environment International|November 15, 2016
Effect of a clean stove intervention on inflammatory biomarkers in pregnant women in Ibadan, Nigeria: A randomized controlled studyChristopher O Olopade, Elizabeth Frank, Emily Bartlett, et al.
Anesthesia and Analgesia|October 17, 2025
A Combined Intravenous and Oral Metoprolol Regimen to Reduce Perioperative Myocardial Injury: The ORION TrialPeter Nagele, Mohammad A Helwani, Eslam Samaha, et al.
The Journal of Urology|December 8, 2025
Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial NephrectomyAlon Lazarovich, Samuel Tremblay, Charlie Nottingham, et al.
Clinical Lung Cancer|November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trialEzra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.
Oncotarget|February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancerShalin Shah, Kevin Wood, Brian Labadie, et al.
Clinical Genitourinary Cancer|September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal CarcinomaRandy F Sweis, Milica Medved, Shannon Towey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignanciesTodd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.
Blood|March 8, 2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesSonali M Smith, Michelle M Le Beau, Dezheng Huo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB AlterationsNoura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Pageof 16